United States · Federal contract register · Supplier record

INHOMEPHARMACY LLC

Line: National defense r&d services; defense-related activities; applied research (AC32)Register loaded to September 2026Compiled 16 October 2026

INHOMEPHARMACY LLC — United States · Federal contract register · Supplier record: 5 contracts, all years ($1,014,952 · Mar 2020 – Apr 2026); $167K since January 2024 (2 contracts · 1 agency); — rank in the line (of 1,457 suppliers · 0.0%); 1 agencies never served ($509M on the line without INHOMEPHARMACY LLC).

Assay record ASY-US-1VFR53N1OQ · Cite as: Assay Systems, “INHOMEPHARMACY LLC: 2 government contracts in the United States since 2024”, https://assay-systems.com/register/us/inhomepharmacy-llc/

5
contracts, all years
$1,014,952 · Mar 2020 – Apr 2026
$167K
since January 2024
2 contracts · 1 agency
—
rank in the line
of 1,457 suppliers · 0.0%
1
agencies never served
$509M on the line without INHOMEPHARMACY LLC

Own record by year

2020 onward
$50.0K
$48.6K
$749K
$142K
$25.0K
2020202120222023202420252026

Who buys from INHOMEPHARMACY LLC

since January 2024
1agencies
$167Kpaid
100.0%top buyer
Department of Defense100.0%
$166,975

Won without a rival

2023-10-03 – 2026-04-24
2uncontested awards
67%of its awards
1without a competition
1single bid

INHOMEPHARMACY LLC won 2 of its 3 public contract awards in United States without a rival from 2023-10-03 to 2026-04-24, worth $167K: 1 without a competition and 1 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Department of the Air Force with 2.

Buyers: Department of the Air Force (2)

Every uncontested award of INHOMEPHARMACY LLC · United States: all uncontested awards

The line

since January 2024
$10.2Bline value
3,580contracts
2agencies
1,457suppliers
63.6%held by top ten

National defense r&d services; defense-related activities; applied research (AC32)

$6.3B
$3.2B
$646M
202420252026Jan–Sep
—of 1,457 suppliers
$0INHOMEPHARMACY LLC in the line
0.0%share of the line

Agencies that buy the line and never bought from INHOMEPHARMACY LLC

1agencies
2contracts
$509,117,561since January 2024
General Services Administration2 contracts
$509,117,561

How the line is bought

by value, since 2024
39%no competition
19%one applicant
0of these to INHOMEPHARMACY LLC
Competed, several suppliers applied2,277 contracts
$4,301,714,274 · 42.3%
Awarded directly, no competition1,009 contracts
$3,971,604,265 · 39.0%
Competed, one supplier applied294 contracts
$1,903,799,204 · 18.7%

Contracts reaching their end dates

Oct 2026 – October 2027
947contracts
$3,671,219,840end by October 2027
127end in February 2027 · $202M
1in agencies never served · $493M
$42.7M
$116M
$827M
$207M
$202M
$246M
$185M
$463M
$169M
$648M
$113M
$433M
$19.9M
Oct 2624 contractsNov 2667 contractsDec 2679 contractsJan 2761 contractsFeb 27127 contractsMar 27111 contractsApr 2771 contractsMay 27100 contractsJun 27105 contractsJul 2748 contractsAug 2740 contractsSep 27100 contractsOct 2714 contracts

Suppliers next to it in the line

since January 2024
GSI ENVIRONMENTAL INC.1 contract · 1 agency
$139,972
INTELLISENSE SYSTEMS INC1 contract · 1 agency
$139,964
LIQUID ION SOLUTIONS LLC1 contract · 1 agency
$139,812
INHOMEPHARMACY LLC
$0

All 1,457 suppliers in the line

Fastest-growing supplier in the line

same line
+434%growth

Supplier UEI KTMAJCY6JXM3

2024 to Sep 2026
$260,130,098
2022–2023
$48,755,456

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.